Literature DB >> 27540976

Expression of BTBD7 in primary salivary adenoid cystic carcinoma and correlation with Slug and prognosis.

Liu Yang1,2,3,1, Tiejun Wang3,1, Jun Zhang2,4, Zhonghao Liu3, Xuxia Wang1,2.   

Abstract

BACKGROUND: BTB/POZ domain-containing protein 7 (BTBD7) is recognized as a regulatory gene that regulates epithelial cell dynamics and branching morphogenesis. It is also reported for regulating epithelial-mesenchymal transition (EMT) molecules and involved in the process of invasion and metastasis of lung cancer and hepatocellular carcinoma. Slug is a transcriptional factor of EMT which plays a crucial role in the process of primary salivary adenoid cystic carcinoma (SACC). However, the role of BTBD7 in SACC and the correlation with Slug have not been identified. This study investigated the expression of BTBD7 and correlation with Slug, as well as the prognostic significance of BTBD7 in SACC.
METHODS: The expression of BTBD7 and Slug were examined in ACC-LM and ACC-83 cell lines and immunohistochemically in paraffin embedded tissue specimens from 66 primary SACC patients. Statistical analyses were performed to evaluate the correlation between BTBD7 expression and Slug expression and the prognostic significance of BTBD7 expression.
RESULTS: BTBD7 protein expression was initially verified in ACC-LM and ACC-83 cell lines. The positive rate of BTBD7 expression was 62.1% in SACC to 20% in normal salivary tissues comparatively. BTBD7 expression was significantly correlated with Slug expression in SACC (P< 0.05). Increased BTBD7 expression was significantly associated with the TNM stage, tissue typing, distant metastasis and patients' poor clinical outcome.
CONCLUSIONS: Positive expression of BTBD7 in SACC could play an important role in the development of cancer and may serve as a favorable predictor for diagnosis and poor prognosis of patients.

Entities:  

Keywords:  BTBD7; Slug; prognosis; salivary adenoid cystic carcinoma

Mesh:

Substances:

Year:  2016        PMID: 27540976     DOI: 10.3233/CBM-160629

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  4 in total

1.  Btbd7 is essential for region-specific epithelial cell dynamics and branching morphogenesis in vivo.

Authors:  William P Daley; Kazue Matsumoto; Andrew D Doyle; Shaohe Wang; Brian J DuChez; Kenn Holmbeck; Kenneth M Yamada
Journal:  Development       Date:  2017-05-15       Impact factor: 6.868

2.  Effects of Btbd7 knockdown on the proliferation of human dental pulp cells and expression of Dspp.

Authors:  Qi Bao; Jun Zhang; Xu-Xia Wang
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

3.  High BTBD7 expression positive is correlated with SLUG-predicted poor prognosis in hormone receptor-negative breast cancer.

Authors:  Zi-Xiong Li; Ze-Nan Huang; Hui Luo; Xiong-Bin Yang; Yu-Lin Wang; Jie-Xin Chen; Xiao-Kai Ma; Feng Xu; Tian-Tian Wang; Ling Lin
Journal:  Ann Transl Med       Date:  2021-08

4.  Artesunate inhibits epithelial-mesenchymal transition in non-small-cell lung cancer (NSCLC) cells by down-regulating the expression of BTBD7.

Authors:  Jing-Si Wang; Ming-Juan Wang; Xiao Lu; Jiao Zhang; Quan-Xing Liu; Dong Zhou; Ji-Gang Dai; Hong Zheng
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.